JP2009535340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535340A5 JP2009535340A5 JP2009507797A JP2009507797A JP2009535340A5 JP 2009535340 A5 JP2009535340 A5 JP 2009535340A5 JP 2009507797 A JP2009507797 A JP 2009507797A JP 2009507797 A JP2009507797 A JP 2009507797A JP 2009535340 A5 JP2009535340 A5 JP 2009535340A5
- Authority
- JP
- Japan
- Prior art keywords
- free base
- crystalline free
- base form
- item
- form according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012458 free base Substances 0.000 claims description 62
- 238000000113 differential scanning calorimetry Methods 0.000 claims description 12
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 9
- 241000124008 Mammalia Species 0.000 claims description 6
- 230000001747 exhibiting effect Effects 0.000 claims description 6
- QMOVGVNKXUTCQU-UHFFFAOYSA-N (2-phenylphenyl)carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1C1=CC=CC=C1 QMOVGVNKXUTCQU-UHFFFAOYSA-N 0.000 claims description 5
- -1 4-{[(R) -2- (3-formylamino-4-hydroxyphenyl) -2-hydroxyethylamino] methyl} -2,5-dimethylphenyl Carbamoyl Chemical group 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 208000019693 Lung disease Diseases 0.000 claims description 4
- YZHRQETVEBXYFP-BBQAJUCSSA-N O[C@@H](CNCC(C=CC1)=CC1(C1=CC=CC=C1)NC(O)=O)C(C=C1)=CC(NC=O)=C1O Chemical compound O[C@@H](CNCC(C=CC1)=CC1(C1=CC=CC=C1)NC(O)=O)C(C=C1)=CC(NC=O)=C1O YZHRQETVEBXYFP-BBQAJUCSSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 230000007883 bronchodilation Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000002294 steroidal antiinflammatory agent Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 108060003345 Adrenergic Receptor Proteins 0.000 claims description 2
- 102000017910 Adrenergic receptor Human genes 0.000 claims description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 claims description 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 4
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79470906P | 2006-04-25 | 2006-04-25 | |
| PCT/US2007/010120 WO2007127297A2 (en) | 2006-04-25 | 2007-04-24 | Crystalline forms of a dimethylphenyl compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009535340A JP2009535340A (ja) | 2009-10-01 |
| JP2009535340A5 true JP2009535340A5 (enExample) | 2011-05-19 |
Family
ID=38556280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507797A Pending JP2009535340A (ja) | 2006-04-25 | 2007-04-24 | ジメチルフェニル化合物の結晶性形態 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7880010B2 (enExample) |
| EP (1) | EP2010490B1 (enExample) |
| JP (1) | JP2009535340A (enExample) |
| CN (1) | CN101426765A (enExample) |
| AR (1) | AR060648A1 (enExample) |
| AT (1) | ATE520660T1 (enExample) |
| CA (1) | CA2650631A1 (enExample) |
| PE (1) | PE20080195A1 (enExample) |
| TW (1) | TW200811104A (enExample) |
| WO (1) | WO2007127297A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
| US7638138B2 (en) * | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
| MXPA05010379A (es) | 2003-03-27 | 2006-05-31 | Bioactis Ltd | Aparato para administrar una medicina en polvo en la cavidad intranasal. |
| US8673360B2 (en) * | 2004-08-10 | 2014-03-18 | Shin Nippon Biomedical Laboratories, Ltd. | Compositions that enable rapid-acting and highly absorptive intranasal administration |
| WO2006023457A1 (en) * | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| US20080071141A1 (en) * | 2006-09-18 | 2008-03-20 | Abhisuek Gattani | Method and apparatus for measuring attributes of an anatomical feature during a medical procedure |
| ES2652415T3 (es) | 2006-12-26 | 2018-02-02 | Shin Nippon Biomedical Laboratories, Ltd. | Preparación para aplicación transnasal |
| US20090216010A1 (en) * | 2008-02-22 | 2009-08-27 | Wei-Hong Tseng | Crystalline carbapenem compound and produced method thereof |
| ES2535326T3 (es) * | 2009-04-14 | 2015-05-08 | Glaxo Group Limited | Procedimiento de preparación de un éster de ácido bifenil-2-ilcarbámico |
| CN103936716B (zh) | 2009-04-23 | 2016-09-07 | 施万呼吸有限责任公司 | 具蕈毒碱受体拮抗剂和β2肾上腺素受体激动剂活性的二酰胺化合物 |
| EP2429495A4 (en) * | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | INTRANASAL PHARMACEUTICAL COMPOSITION WITH IMPROVED PHARMACOKINETICS |
| WO2011013003A2 (en) | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
| WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
| EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
| AR083115A1 (es) | 2010-09-30 | 2013-01-30 | Theravance Inc | Sales oxalato cristalinas de un compuesto diamida |
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| WO2014175234A1 (ja) * | 2013-04-26 | 2014-10-30 | 富士フイルム株式会社 | 撮像装置及び画像表示方法 |
| CN107108502A (zh) * | 2015-05-14 | 2017-08-29 | 四川海思科制药有限公司 | 具有β2受体激动及M受体拮抗活性的联苯衍生物及其在医药上的用途 |
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006635A1 (en) | 1993-09-02 | 1995-03-09 | Yamanouchi Pharmaceutical Co., Ltd. | Carbamate derivative and medicine containing the same |
| KR970701174A (ko) | 1994-02-10 | 1997-03-17 | 오노다 마사요시 | 신규한 카바메이트 유도체 및 이의 의약 조성물(Novel carbamate derivative and medicinal composition containing the same) |
| US6040344A (en) | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| UA73965C2 (en) | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
| US20030018019A1 (en) | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| US6653323B2 (en) | 2001-11-13 | 2003-11-25 | Theravance, Inc. | Aryl aniline β2 adrenergic receptor agonists |
| PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
| EP1622875B1 (en) * | 2003-05-08 | 2009-12-02 | Theravance, Inc. | Crystalline forms of an arylaniline beta-2 adrenergic receptor agonist |
| DE602004021959D1 (de) * | 2003-11-21 | 2009-08-20 | Theravance Inc | Verbindungen mit agonistischer wirkung am beta2-adrenergen rezeptor und am muscarinischen rezeptor |
| WO2006023460A2 (en) | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
| WO2006023457A1 (en) | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| US7558576B2 (en) * | 2005-03-29 | 2009-07-07 | Qualcomm Incorporated | Employing frequency offset to compensate for Doppler shift |
| TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
-
2007
- 2007-04-23 TW TW096114174A patent/TW200811104A/zh unknown
- 2007-04-24 EP EP07794375A patent/EP2010490B1/en active Active
- 2007-04-24 CN CNA2007800142180A patent/CN101426765A/zh active Pending
- 2007-04-24 JP JP2009507797A patent/JP2009535340A/ja active Pending
- 2007-04-24 AT AT07794375T patent/ATE520660T1/de not_active IP Right Cessation
- 2007-04-24 WO PCT/US2007/010120 patent/WO2007127297A2/en not_active Ceased
- 2007-04-24 AR ARP070101778A patent/AR060648A1/es unknown
- 2007-04-24 CA CA002650631A patent/CA2650631A1/en not_active Abandoned
- 2007-04-24 PE PE2007000508A patent/PE20080195A1/es not_active Application Discontinuation
- 2007-04-24 US US11/789,154 patent/US7880010B2/en not_active Expired - Fee Related
-
2010
- 2010-12-16 US US12/970,013 patent/US20110086881A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009535340A5 (enExample) | ||
| JP2012533550A5 (enExample) | ||
| TWI659028B (zh) | 苯并咪唑衍生物（（Ｓ）-４-（５，７-二氟唍-４-基氧基）-Ｎ，Ｎ，２-三甲基-１Ｈ-苯并[ｄ]咪唑-６-甲醯胺）之酸加成鹽 | |
| JP5039279B2 (ja) | ３−ｚ−［１−（４−（ｎ−（（４−メチル−ピペラジン−１−イル）−メチルカルボニル）−ｎ−メチル−アミノ）−アニリノ）−１−フェニル−メチレン］−６−メトキシカルボニル−２−インドリノン−モノエタンスルホネート及び医薬組成物としてのそれらの使用 | |
| CN102388021B (zh) | 吡咯烷鎓盐的制备方法 | |
| TWI834791B (zh) | 吡咯啶化合物的結晶 | |
| JP2008513358A5 (enExample) | ||
| RU2007109598A (ru) | Кристаллическая форма бифенильного соединения | |
| JP2009084270A (ja) | 塩形態 | |
| EA022018B1 (ru) | Кристаллические оксалатные соли диамидного соединения | |
| JP2013538857A5 (enExample) | ||
| TW200808726A (en) | Novel polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| RU2011110745A (ru) | [4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1н-индол-3-ил]-метанон как ингибитор триптазы тучных клеток | |
| JP2023103328A (ja) | ビランテロールトリフェニル酢酸塩の新規な結晶形態及びこれらの調製プロセス | |
| CN110831930A (zh) | 杂环亚基乙酰胺衍生物的晶体 | |
| JP2007530580A5 (enExample) | ||
| JP2012512145A (ja) | フリバンセリンの結晶性の塩形態 | |
| JP2006104184A (ja) | ストロンチウムラネレートのアルファー（α）−結晶形、その製造方法、及びそれを含む医薬組成物 | |
| JP2014516341A (ja) | アゴメラチンの新しい結晶形ｖｉｉ、その調製方法及び使用並びにこれを含有する医薬組成物 | |
| RU2451016C2 (ru) | Тозилатная соль транс-n-изобутил-3-фтор-3-[3-фтор-4-(пирролидин-1-илметил)фенил]циклобутанкарбоксамида | |
| JP2006501207A5 (enExample) | ||
| JP2006506402A (ja) | 四級アンモニウム化合物およびその抗ムスカリン薬としての使用 | |
| US20140163071A1 (en) | Bioavailable compositions of amorphous piperidinyl compounds | |
| JP2018509421A (ja) | ニンテダニブジエタンスルホン酸塩結晶並びにその製造方法および使用 |